Bimatoprost

Synonyms: N-Ethyl-9Alpha,11Alpha,15S-Trihydroxy-17-Phenyl-18,19,20-Trinor-Prosta-5Z, 13E-Dien-1-Amide; LUMIGAN; Bimatoprost(TM); 17-phenyl TRINOR prostaglandin F2ALPHA ethyl amide

Product Categories: Prostaglandins;Prostaglandin;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;Arachidonic Acid Cascade;Lipids in Cell Signaling;Lumigan 

CAS: 155206-00-1

MF: C25H37NO4

MW: 415.5656

Assay: 99%

Appearance: White powder

Density 1.145g/cm3

Boiling point 629.8°C at 760 mmHg

Refractive index 1.591

Flash point 334.7°C

Vapour Pressur 9.94E-17mmHg at 25°C

2.  Descriptions:

Bimatoprost (marketed in the U.S., Canada and Europe by Allergan, under the trade name Lumigan) is a prostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. In December 2008, the indication to lengthen eyelashes was approved by the U.S. Food and Drug Administration (FDA); the cosmetic formulation of bimatoprost is sold as Latisse. In 2008-2011, at least three case series suggested that bimatoprost has the ability to reduce adipose (fat) tissue.